MURRAY HOUSE CLINIC BERWICK
MURRAY HOUSE
CLINIC
BERWICK
- (03) 9796 2222
OPENING HOURS
Monday 8:30am–5pm
Tuesday 8:30am–5pm
Wednesday 8:30am–5pm
Thursday 8:30am–5pm
Friday 8:30am–5pm
Saturday 8:30am–1pm
Sunday Closed
ADDRESS
Level 1, 14 Langmore Lane, Berwick
- (03) 9796 2222
OPENING HOURS
Monday 8:30am–5pm
TUesday 8:30am–5pm
Wednesday 8:30am–5pm
Thursday 8:30am–5pm
Friday 8:30am–5pm
Saturday 8:30am–1pm
Sunday Closed
ADDRESS
Level 1, 14 Langmore Lane, Berwick
Thank you for choosing our clinic. We sincerely hope that we can develop a mutually beneficial and professional relationship. Please take a few moments to read our information sheet so that you can make the most of the services that we offer.
Murray House Clinic is an accredited clinic and all the doctors are vocationally registered with a wide variety of experience in family medicine.
Murray House Clinic is a family general practice medical clinic that has provided high quality healthcare to the south east of Melbourne for more than 100 years.
Since its establishment in 1907, Murray House Clinic has been committed to providing the best quality, care and standards.
Our caring team of doctors and nurses provide compassionate, holistic, patient centred care, focused on proactively supporting individual health needs.
LATEST NEWS
From 3rd Feb 2025, eligible pregnant women will be able to receive the respiratory syncytial virus (RSV) vaccine for free under the National Immunisation Program (NIP).
The RSV vaccine is recommended for women at 28 to 36 weeks of pregnancy and it protects their newborn from RSV.
RSV is a serious disease for newborn babies and it infects their nose, throat, and lungs. It is a leading cause of children going to hospital. Getting a vaccine in pregnancy reduces the risk of severe RSV disease in infants less than 6 months of age by about 70%.
Infant immunisation
There will be a RSV vaccination available for infants whose mothers did not receive the RSV vaccine during pregnancy. The program will run from 1 April to 30 September 2025.
Under the new program, a free long-acting RSV monoclonal antibody, Beyfortus™ (nirsevimab), will be offered to eligible infants and young children.
Eligible infants are
Infants born from 1 October 2024 – 31 March 2025:
- (Up to 8 months of age only) to mothers who did not receive maternal RSV vaccine during pregnancy, or where maternal RSV vaccine was administered 2 weeks before birth, or
- with risk conditions for severe RSV disease (Australian Immunisation Handbook) regardless of maternal vaccination.
- Aboriginal and Torres Strait islanders infants born after the 1st October 2023
